Friday, May 1, 2020NIAID Now: New NIAID Study Examines Immune Responses in People Hospitalized with COVID-19Today, a new NIAID-supported study has begun to track the immune responses of people hospitalized with COVID-19 in 10 research sites across the United States. Investigators in NIAID’s Human Immunology Project Consortium (HIPC) in collaboration with researchers in the Asthma and Allergic Diseases Clinical Research Consortium (AADCRC) and other NIAID-funded groups, aim to determine how certain immunological measures correspond to, or may even predict, the clinical severity of COVID-19. Data collected in the Immunophenotyping Assessment in a COVID-19 Cohort, or IMPACC, study will help inform recommendations for COVID-19 care and, hopefully, identify new targets and optimal timing for experimental treatments. |
Los avances de la medicina en el campo de la genética, por ende de la herencia, están modificando el paisaje del conocimiento médico de las enfermedades. Este BLOG intenta informar acerca de los avances proveyendo orientación al enfermo y su familia así como información científica al profesional del equipo de salud de habla hispana.
viernes, 1 de mayo de 2020
New NIAID Study Examines Immune Responses in People Hospitalized with COVID-19 | NIH: National Institute of Allergy and Infectious Diseases
New NIAID Study Examines Immune Responses in People Hospitalized with COVID-19 | NIH: National Institute of Allergy and Infectious Diseases
No hay comentarios:
Publicar un comentario